Zymeworks (ZYME) Form 3 Zymeworks / Neil Josephson ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Josephson Neil

(Last) (First) (Middle)

C/O ZYMEWORKS INC.

1385 WEST 8TH AVENUE, SUITE 540

(Street)

VANCOUVER A1 V6H 3V9

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/16/2021

3. Issuer Name and Ticker or Trading Symbol
Zymeworks Inc. [ ZYME ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Interim Chief Medical Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	1,593	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	05/05/2029	Common Shares	80,000	19.11	D
Stock Option (Right to Buy)	(2)	03/09/2030	Common Shares	13,125	35.2	D
Stock Option (Right to Buy)	(3)	03/09/2031	Common Shares	30,000	34.82	D
Stock Option (Right to Buy)	(4)	05/05/2031	Common Shares	15,000	29.49	D
Restricted Stock Unit	(5)	(5)	Common Shares	1,459	(6)	D
Restricted Stock Unit	(7)	(7)	Common Shares	5,000	(6)	D

Explanation of Responses:

1. Stock options vest as follows: (i) 25% on May 6, 2020 (the first anniversary of grant date) and (ii) remainder in 36 equal monthly installments on last day of each month following first anniversary of grant date.

2. Stock options vest as follows: (i) 25% on March 10, 2021 (the first anniversary of grant date) and (ii) remainder in 36 equal monthly installments on last day of each month following first anniversary of grant date.

3. Stock options vest as follows: (i) 25% on March 10, 2022 (the first anniversary of grant date) and (ii) remainder in 36 equal monthly installments on last day of each month following first anniversary of grant date.

4. Stock options vest as follows: (i) 25% on May 6, 2022 (the first anniversary of grant date) and (ii) remainder in 36 equal monthly installments on last day of each month following first anniversary of grant date.

5. The restricted stock units vest in two equal annual installments beginning on March 10, 2022.

6. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

7. The restricted stock units vest in three equal annual installments beginning on March 10, 2022.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

	/s/ Daniel Dex, Attorney-in-Fact	05/25/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.